Embecta Corp. (EMBC) Stock

Healthcare · Medical Instruments & Supplies · Member of Other US Stocks

Embecta Corp. (EMBC) closed at USD 6.18 on 2026-10-14, a change of -54.5 % over the past year, with a market capitalization of USD 365.45M.

Embecta Corp. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Embecta Corp. key figures

Previous close

USD 6.18 (2026-10-14)

1-year change

-54.5 %

Market cap

USD 365.45M

Enterprise value

USD 1.65B

P/E ratio (trailing)

4.24

P/E ratio (forward)

3.66

EPS (trailing)

1.52

EPS (forward)

1.76

PEG ratio

n/a

Price to book

-0.60

Revenue growth

-8.1 %

Earnings growth

-53.7 %

Dividend per share (trailing)

0.46

Short ratio

4.70

Employees

1,850

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Embecta Corp.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Embecta Corp. and compare it with other stocks.